<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33766915</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2025102118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2025102118</ELocationID><Abstract><AbstractText>Microglial-derived inflammation has been linked to a broad range of neurodegenerative and neuropsychiatric conditions, including amyotrophic lateral sclerosis (ALS). Using single-cell RNA sequencing, a class of Disease-Associated Microglia (DAMs) have been characterized in neurodegeneration. However, the DAM phenotype alone is insufficient to explain the functional complexity of microglia, particularly with regard to regulating inflammation that is a hallmark of many neurodegenerative diseases. Here, we identify a subclass of microglia in mouse models of ALS which we term RIPK1-Regulated Inflammatory Microglia (RRIMs). RRIMs show significant up-regulation of classical proinflammatory pathways, including increased levels of <i>Tnf</i> and <i>Il1b</i> RNA and protein. We find that RRIMs are highly regulated by TNF&#x3b1; signaling and that the prevalence of these microglia can be suppressed by inhibiting receptor-interacting protein kinase 1 (RIPK1) activity downstream of the TNF receptor 1. These findings help to elucidate a mechanism by which RIPK1 kinase inhibition has been shown to provide therapeutic benefit in mouse models of ALS and may provide an additional biomarker for analysis in ongoing phase 2 clinical trials of RIPK1 inhibitors in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mifflin</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1607-5851</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhirui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Statistics, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dufort</LastName><ForeName>Connor</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>F. M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hession</LastName><ForeName>Cynthia C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Alec J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0001-7619-0662</Identifier><AffiliationInfo><Affiliation>F. M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Kongyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jun S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-4450-7239</Identifier><AffiliationInfo><Affiliation>Department of Statistics, Harvard University, Cambridge, MA 02138.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Joshua Z</ForeName><Initials>JZ</Initials><Identifier Source="ORCID">0000-0002-0170-3598</Identifier><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stevens</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>F. M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA 02142.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Junying</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2405-6036</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115; junying_yuan@sioc.ac.cn chengyu_zou@hms.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Chengyu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5793-0247</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115; junying_yuan@sioc.ac.cn chengyu_zou@hms.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RF1 AG055521</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C587672">IL1B protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501288">Optn protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000630923">Tnf protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D053422">Receptor-Interacting Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C506251">Ripk1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008817" MajorTopicYN="N">Mice, Mutant Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053422" MajorTopicYN="N">Receptor-Interacting Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RIPK1</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">scRNAseq</Keyword></KeywordList><CoiStatement>Competing interest statement: J.Y. is a consultant for Denali Therapeutics and Sanofi. J.Y. and J.M.H. are co-authors on a 2018 Nomenclature review article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33766915</ArticleId><ArticleId IdType="pmc">PMC8020785</ArticleId><ArticleId IdType="doi">10.1073/pnas.2025102118</ArticleId><ArticleId IdType="pii">2025102118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ransohoff R. M., How neuroinflammation contributes to neurodegeneration. Science 353, 777&#x2013;783 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27540165</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter M. W., Stevens B., Microglia emerge as central players in brain disease. Nat. Med. 23, 1018&#x2013;1027 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28886007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay M. E., et al. ., The role of microglia in the healthy brain. J. Neurosci. 31, 16064&#x2013;16069 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6633221</ArticleId><ArticleId IdType="pubmed">22072657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Dissing-Olesen L., MacVicar B. A., Stevens B., Microglia: Dynamic mediators of synapse development and plasticity. Trends Immunol. 36, 605&#x2013;613 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4841266</ArticleId><ArticleId IdType="pubmed">26431938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond T. R., et al. ., Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253&#x2013;271.e6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q., et al. ., Developmental heterogeneity of microglia and brain myeloid cells revealed by deep single-cell RNA sequencing. Neuron 101, 207&#x2013;223.e10 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6336504</ArticleId><ArticleId IdType="pubmed">30606613</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., et al. ., A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell 169, 1276&#x2013;1290.e17 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., et al. ., The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566&#x2013;581.e9 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719893</ArticleId><ArticleId IdType="pubmed">28930663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulland T. K., et al. ., TREM2 maintains microglial metabolic fitness in Alzheimer&#x2019;s disease. Cell 170, 649&#x2013;663.e13 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5573224</ArticleId><ArticleId IdType="pubmed">28802038</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Amin P., Ofengeim D., Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat. Rev. Neurosci. 20, 19&#x2013;33 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342007</ArticleId><ArticleId IdType="pubmed">30467385</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group , TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study. Neurology 53, 457&#x2013;465 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10449104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tweedie D., Sambamurti K., Greig N. H., TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: New drug candidates and targets. Curr. Alzheimer Res. 4, 378&#x2013;385 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17908040</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D., Yuan J., Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 14, 727&#x2013;736 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24129419</ArticleId></ArticleIdList></Reference><Reference><Citation>Christofferson D. E., et al. ., A novel role for RIP1 kinase in mediating TNF&#x3b1; production. Cell Death Dis. 3, e320 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3388236</ArticleId><ArticleId IdType="pubmed">22695613</ArticleId></ArticleIdList></Reference><Reference><Citation>Polykratis A., et al. ., Cutting edge: RIPK1 kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 193, 1539&#x2013;1543 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4119562</ArticleId><ArticleId IdType="pubmed">25015821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shutinoski B., et al. ., K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo. Cell Death Differ. 23, 1628&#x2013;1637 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5041191</ArticleId><ArticleId IdType="pubmed">27258786</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A., et al. ., Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 4, 313&#x2013;321 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5434866</ArticleId><ArticleId IdType="pubmed">18408713</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A., et al. ., Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112&#x2013;119 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16408008</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A., Maki J. L., Yuan J., Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 20, 366 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554332</ArticleId><ArticleId IdType="pubmed">23197295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y., et al. ., RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353, 603&#x2013;608 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D., et al. ., RIPK1 mediates a disease-associated microglial response in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. U.S.A. 114, E8788&#x2013;E8797 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642727</ArticleId><ArticleId IdType="pubmed">28904096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D., et al. ., Activation of necroptosis in multiple sclerosis. Cell Rep. 10, 1836&#x2013;1849 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4494996</ArticleId><ArticleId IdType="pubmed">25801023</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J. S., et al. ., Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55, 221&#x2013;235 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda C., et al. ., TNF and sTNFR1/2 plasma levels in ALS patients. J. Neuroimmunol. 194, 123&#x2013;131 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18083240</ArticleId></ArticleIdList></Reference><Reference><Citation>Olesen M. N., et al. ., Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflamm. 7, e697 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136052</ArticleId><ArticleId IdType="pubmed">32123048</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D., et al. ., TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell 174, 1477&#x2013;1491.e19 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., et al. ., An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929&#x2013;11947 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4152602</ArticleId><ArticleId IdType="pubmed">25186741</ArticleId></ArticleIdList></Reference><Reference><Citation>Macosko E. Z., et al. ., Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202&#x2013;1214 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4481139</ArticleId><ArticleId IdType="pubmed">26000488</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M. E., et al. ., Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772&#x2013;1775 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A., Hoffman P., Smibert P., Papalexi E., Satija R., Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411&#x2013;420 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Satija R., Farrell J. A., Gennert D., Schier A. F., Regev A., Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495&#x2013;502 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430369</ArticleId><ArticleId IdType="pubmed">25867923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancarci B. O., et al. ., Cross-laboratory analysis of brain cell type transcriptomes with applications to interpretation of bulk tissue data. eNeuro 4, ENEURO.0212-17.2017 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5707795</ArticleId><ArticleId IdType="pubmed">29204516</ArticleId></ArticleIdList></Reference><Reference><Citation>Heng T. S., Painter M. W.; Immunological Genome Project Consortium , The immunological genome project: Networks of gene expression in immune cells. Nat. Immunol. 9, 1091&#x2013;1094 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18800157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahney J., von Bartheld C. S., The cellular composition and glia-neuron ratio in the spinal cord of a human and a nonhuman primate: Comparison with other species and brain regions. Anat. Rec. (Hoboken) 301, 697&#x2013;710 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5845477</ArticleId><ArticleId IdType="pubmed">29150977</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellino F., et al. ., Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440, 890&#x2013;895 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16612374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E. G., et al. ., Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350&#x2013;2354 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582399</ArticleId><ArticleId IdType="pubmed">11009421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wertz I. E., et al. ., De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694&#x2013;699 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15258597</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins N. D., Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49&#x2013;62 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17183360</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrand D. G., et al. ., I&#x3ba;B&#x3b6; is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 190, 4812&#x2013;4820 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23547114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu K., et al. ., Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression. Cell Death Dis. 9, 500 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923285</ArticleId><ArticleId IdType="pubmed">29703889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I. M., et al. ., A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385&#x2013;401 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X., et al. ., Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309&#x2013;315 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5330805</ArticleId><ArticleId IdType="pubmed">28114287</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu X., et al. ., Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979&#x2013;982 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764547</ArticleId><ArticleId IdType="pubmed">28825705</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapnell C., et al. ., The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381&#x2013;386 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122333</ArticleId><ArticleId IdType="pubmed">24658644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilionis R., et al. ., Single-cell barcoding and sequencing using droplet microfluidics. Nat. Protoc. 12, 44&#x2013;73 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27929523</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein A. M., et al. ., Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187&#x2013;1201 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441768</ArticleId><ArticleId IdType="pubmed">26000487</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa T., et al. ., Optineurin in neurodegenerative diseases. Neuropathology 31, 569&#x2013;574 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21284751</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M., et al. ., Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol. Dis. 8, 933&#x2013;941 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding J., et al. ., Systematic comparison of single-cell and single-nucleus RNA-sequencing methods. Nat. Biotechnol. 38, 737&#x2013;746 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7289686</ArticleId><ArticleId IdType="pubmed">32341560</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh S. E., et al. ., Single cell sequencing reveals glial specific responses to tissue processing &amp; enzymatic dissociation in mice and humans. bioRxiv [Preprint] (2020). 10.1101/2020.12.03.408542 (Accessed 3 December 2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.03.408542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mifflin L., Ofengeim D., Yuan J., Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat. Rev. Drug Discov. 19, 553&#x2013;571 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362612</ArticleId><ArticleId IdType="pubmed">32669658</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S. A., et al. ., Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481&#x2013;487 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R. S., et al. ., Neuroinflammation during RNA viral infections. Annu. Rev. Immunol. 37, 73&#x2013;95 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6731125</ArticleId><ArticleId IdType="pubmed">31026414</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf Y., et al. ., Microglial MHC class II is dispensable for experimental autoimmune encephalomyelitis and cuprizone-induced demyelination. Eur. J. Immunol. 48, 1308&#x2013;1318 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29697861</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer G. J., Torricelli J. R., Isolation and culture of adult neurons and neurospheres. Nat. Protoc. 2, 1490&#x2013;1498 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17545985</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., et al. ., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Hitomi J., et al. ., Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 135, 1311&#x2013;1323 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2621059</ArticleId><ArticleId IdType="pubmed">19109899</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter A. E., et al. ., CellProfiler: Image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1794559</ArticleId><ArticleId IdType="pubmed">17076895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamprecht M. R., Sabatini D. M., Carpenter A. E., CellProfiler: Free, versatile software for automated biological image analysis. Biotechniques 42, 71&#x2013;75 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17269487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>